Media CoverageDecember 5, 2023BillionToOne recognized as one of the most promising digital health companies of 2023 by CB InsightsRead
Press ReleasesOctober 30, 2023BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy PopulationRead
Press ReleasesAugust 11, 2023BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% AccuracyRead
Media CoverageMay 1, 2023BillionToOne, Inc., Secures Landmark Win in Lawsuit Against CDPH’s PNS Program in Order to Maintain Patient and Provider Choice Regarding Cell-free DNA Screening for Trisomy 21, 18, and 13Read
Press ReleasesJanuary 23, 2023BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial UseRead
Press ReleasesDecember 16, 2022BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company’s Rapid GrowthRead